Watch the full video from the EASD 2025 Annual Meeting to learn more about the emerging global consensus on screening for early-stage type 1 diabetes and its implications for clinical practice, public health, and prevention research.
In this episode, Annette Ziegler (Helmholtz Munich), Chantal Mathieu (KU Leuven & EASD President), and Anastasia Albanese-O’Neill (Breakthrough T1D) discuss:
Why early detection matters for preventing diabetic ketoacidosisRecommended screening ages and the three-time childhood screening modelThe two-step testing approach and its >99% specificityHow early diagnosis enables access to disease-modifying therapiesPolicy considerations for national and regional screening programmesFuture directions, including genetic and polygenic risk screeningStay tuned for more expert insights and breakthrough conversations from EASD TV. To learn more about our expert speakers:
Prof. Anette Ziegler Anastasia Ablanese-O'NeillProf. Chantal Mathieu